A Phase 2 interventional study of high intensity functional exercise in Cerebrovascular Accident and Musculoskeletal Equilibrium, sponsored by Umeå University. Completed at 1 site in Sweden. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2008-10-29.
Sponsored by Umeå University · Phase 2 and Interventional
The purpose of this study is to evaluate a 5-week intervention program targeted at improving balance and functional skills for people with stroke.
Many people with stroke experience a deterioration in balance and a functional decline due to hemiplegic muscle strength. This tend to restrict the persons activity in daily life and also leads to a low falls self efficacy.
High intensity exercise have shown to be effective for improving strength and balance for older people in general living in residential care facilities. It is interesting to see if this high intensity exercise also is applicable in the older stroke population.
Comparison: An intervention group receives three training sessions per week and one theory session per week during 5 weeks, compared to a control group that receives one theory session per week during 5 weeks.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's enrollment of 34 is below the median of 50 across 5,369 interventional studies indexed under Stroke.
Browse Stroke studies →Umeå University is the lead sponsor of 263 studies on the registry; 60 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
high intensity functional exercise
Improvement in balance
Time frame: post, 3 & 6 months
Reduced falls
Time frame: post, 3 & 6 months
Improved self-efficacy
Time frame: post, 3 & 6 months
Improved ADL
Time frame: post, 3 & 6 months
Improved walking ability
Time frame: post, 3 & 6 months
This study is completed, as verified in Oct 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Umeå University